Clinical Trial

Leucine-rich α2-glycoprotein Correlation With Clinical, Endoscopic and Histological Disease Activity of IBD in a EuRopean Context

Name: Leucine-rich α2-glycoprotein Correlation With Clinical, Endoscopic and Histological Disease Activity of IBD in a EuRopean Context — clinical trial record (NCT07621783)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: LEADER

Recruiting

View on ClinicalTrials.gov →

Summary

Prospectively study the correlation between Leucine-rich α2-glycoprotein (LRG) and clinical/endoscopic/histological disease activity in patients with inflammatory bowel disease (IBD) in Europe.

Trial Details

NCT Number	NCT07621783
Lead Sponsor	Imelda GI Clinical Research Center
Conditions	Crohn Disease (CD), Ulcerative Colitis (UC)
Enrollment	100 participants
Start Date	2026-05-01
Primary Completion	2026-12-31 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-06-02